Clinical Study of Apatinib Combined With Second - Line Chemotherapy for Metastatic Colorectal Cancer
Clinical trial NCT03412994 · UNKNOWN
Trial details
- NCT number
- NCT03412994
- Sponsor
- Liqiang Zhong
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-28
- Primary completion
- 2020-02-28
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.